Glucos Baxter Viaflo 100 mg/ml Innrennslislyf, lausn 100 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

glucos baxter viaflo 100 mg/ml innrennslislyf, lausn 100 mg/ml

baxter medical ab* - glucosum - innrennslislyf, lausn - 100 mg/ml

Glucos Baxter Viaflo 50 mg/ml Innrennslislyf, lausn 50 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

glucos baxter viaflo 50 mg/ml innrennslislyf, lausn 50 mg/ml

baxter medical ab* - glucosum - innrennslislyf, lausn - 50 mg/ml

Glucos Fresenius Kabi (Glucos 100 mg/ml Fresenius Kabi) Innrennslislyf, lausn 100 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

glucos fresenius kabi (glucos 100 mg/ml fresenius kabi) innrennslislyf, lausn 100 mg/ml

fresenius kabi ab - glucosum - innrennslislyf, lausn - 100 mg/ml

Glucos Fresenius Kabi (Glucos 200 mg/ml Fresenius Kabi) Innrennslislyf, lausn 200 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

glucos fresenius kabi (glucos 200 mg/ml fresenius kabi) innrennslislyf, lausn 200 mg/ml

fresenius kabi ab - glucosum - innrennslislyf, lausn - 200 mg/ml

Glucos Fresenius Kabi (Glucos 50 mg/ml Fresenius Kabi) Innrennslislyf, lausn 50 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

glucos fresenius kabi (glucos 50 mg/ml fresenius kabi) innrennslislyf, lausn 50 mg/ml

fresenius kabi ab - glucosum - innrennslislyf, lausn - 50 mg/ml

Glucos Fresenius Kabi (Glucos 500 mg/ml Fresenius Kabi) Innrennslislyf, lausn 500 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

glucos fresenius kabi (glucos 500 mg/ml fresenius kabi) innrennslislyf, lausn 500 mg/ml

fresenius kabi ab - glucosum - innrennslislyf, lausn - 500 mg/ml

Plasmalyte Glucos 50 mg/ml Innrennslislyf, lausn 50 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

plasmalyte glucos 50 mg/ml innrennslislyf, lausn 50 mg/ml

baxter medical ab* - glucosum; natrii chloridum; kalii chloridum; magnesii chloridum; natrii acetas; natrii gluconas - innrennslislyf, lausn - 50 mg/ml

Pombiliti Evrópusambandið - íslenska - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Trulicity Evrópusambandið - íslenska - EMA (European Medicines Agency)

trulicity

eli lilly nederland b.v. - dúlaglútíð - sykursýki, tegund 2 - drugs used in diabetes, blood glucose lowering drugs, excl. insulins - trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. fyrir rannsókn árangri með tilliti til sturtu, áhrif á blóðsykursstjórnun og hjarta viðburði, og íbúa rannsakað, sjáðu kafla 4. 4, 4. 5 og 5.

Nexviadyme Evrópusambandið - íslenska - EMA (European Medicines Agency)

nexviadyme

sanofi b.v. - avalglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).